[1] |
MENG Shi, WANG Zhongqun.
Research progress on human immunodeficiency virus-associated pulmonary arterial hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(12): 1431-1440.
|
[2] |
WANG Rui, PAN Jinjin, LI Hua, YUAN Yuhui.
Research progress of melatonin on pulmonary hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 444-448.
|
[3] |
HU Xiaoyan, XU Qiuping.
Application of levosimendan in severe patients after cardiac surgery
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1027-1032.
|
[4] |
WANG Chao, GeGentuya, XU Lei.
Mechanisms of bortezomib in the treatment of pulmonary hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 957-960.
|
[5] |
CHEN Yanbin, DENG Shanshan.
Effect of Xingnaojing injection on the expression of hypoxia-inducible factor-1α in patients with acute cerebral infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(7): 821-824.
|
[6] |
XU Jing, JIN Xiaojie.
Effect of fasudil combined with sildenafil in the treatment of pulmonary hypertension in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(3): 281-286.
|
[7] |
HUANG You-ming, WANG An-cai, ZHA Ri-tian.
Observation on combined seretide with theophylline on the pulmonary artery pressure and right cardiac functionin in patients with stable chronic obstructive pulmonary disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(8): 920-925.
|
[8] |
WU Cai-xia, DU Guan-hua.
Pulmonary vascular endothelial injury and pulmonary hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(4): 463-471.
|
[9] |
WU Jun, WANG Liang-xing, YING Bing-yu, SHI Meng-ru.
Change of calreticulin precursor in pulmonary hypertension rats interfered with puerarin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(1): 14-19.
|
[10] |
MO Bi-wen, ZENG Jin-rong, LI Guo-jian, HUANG Wen-xin, YU Fang, WANG Ji-ying, WANG Chang-ming.
Effects of chloride channel blocker on hypoxia induced rat pulmonary hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(6): 677-680.
|
[11] |
.
Affinity and selectivity of darusentan for rat endothelin receptors and effects of once iv administration of darusentan on hypoxia-induced pulmonary hypertensive in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(3): 261-265.
|
[12] |
WANG Hong, XIE Wei-ping, WANG Hai, HU Gang.
Effects of iptakalim on endothelin-1-induced pulmonary hypertension in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(1): 9-14.
|
[13] |
CHEN Yan-fan, CHEN Shao-Xian, FAN Xiao-Fang, WANG Liang-Xing.
Expression of vascular endothelial growth factor in chronic hypoxia and hypercapnia rats and effects of SHENYI Capsule
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(6): 709-712.
|
[14] |
YANG Peng-Lin, YU Lin-Sheng, GONG Yong-Sheng, ZHENG Lu-Zhen, WANG Wei, HU Liang-Gang.
Influences of perindopril on pulmonary vascular remodeling in normobaric hypoxia-hypercapnia rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2000, 5(4): 305-308.
|
[15] |
CHEN Cheng-Shui, CAI Kong-Chang.
Protective effect of heparin on the changes of pulmonary circulation induced by chronic hypoxia-hypercapnia in rat
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1999, 4(1): 43-45.
|